SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-031584
Filing Date
2024-03-14
Accepted
2024-03-14 16:38:50
Documents
72
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K life-20231231.htm   iXBRL 10-K 2455234
2 EX-4.6 life-ex4_6.htm EX-4.6 36945
3 EX-10.19 life-ex10_19.htm EX-10.19 12978
4 EX-23.1 life-ex23_1.htm EX-23.1 10166
5 EX-31.1 life-ex31_1.htm EX-31.1 10997
6 EX-31.2 life-ex31_2.htm EX-31.2 11073
7 EX-32.1 life-ex32_1.htm EX-32.1 7106
8 EX-32.2 life-ex32_2.htm EX-32.2 6664
9 EX-97.1 life-ex97_1.htm EX-97.1 54417
10 GRAPHIC img144823663_0.jpg GRAPHIC 513002
  Complete submission text file 0000950170-24-031584.txt   11193048

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT life-20231231.xsd EX-101.SCH 1426131
74 EXTRACTED XBRL INSTANCE DOCUMENT life-20231231_htm.xml XML 1760931
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37378 | Film No.: 24750827
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)